ArticleBMC nephrology2026
Biclonal gammopathy with coexistent proximal tubulopathy and cast nephropathy in multiple myeloma: a rare case report.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundMultiple myeloma is a hematological malignancy originating from neoplastic plasma cells, typically characterized by the presence of a monoclonal immunoglobulin. Light chain cast nephropathy is the most common cause of acute kidney injury in myeloma patients, typically presenting with elevated serum creatinine. Light-chain proximal tubulopathy is a manifestation of monoclonal light chain-associated renal injury, characterized by the accumulation of free light chains within proximal tubular cells. However, the co-occurrence of κ light-chain MM with an additional IgG-λ monoclonal band, cast nephropathy with normal serum creatinine, and light-chain proximal tubulopathy is extremely rare, posing significant challenges to diagnosis and treatment. This case report aims to enrich the clinical understanding of such rare comorbidities. CASE PRESENTATION: A 54-year-old female was admitted due to "detection of urinary protein for 2 months". Laboratory tests showed massive proteinuria, mild anemia, normal serum creatinine, and significantly abnormal serum free light chains. Serum immunofixation electrophoresis revealed monoclonal IgG-λ and free κ chains, while urine immunofixation electrophoresis only showed free κ chain positivity. Renal biopsy confirmed κ-type cast nephropathy, with irregular lysosomes in proximal tubular epithelial cells and dominant κ light chain expression. Bone marrow examinations indicated plasma cell myeloma. The final diagnosis was the final diagnosis was confirmed as κ light-chain multiple myeloma with an additional IgG-λ monoclonal band, complicated with cast nephropathy and light-chain proximal tubulopathy. After two courses of chemotherapy, urinary protein and serum free light chain levels improved significantly, but hemoglobin decreased to severe anemia. Subsequent bone marrow aspiration indicated severe erythroid hypoplasia, then the treatment was adjusted, and the hemoglobin level improved subsequently.
conclusionsThis rare case demonstrates that multiple myeloma can harbor two clones and can present with concurrent cast nephropathy and light chain proximal tubulopathy, even when serum creatinine remains normal. Additionally, the transient improvement followed by severe erythroid hypoplasia after chemotherapy suggests the need for close monitoring of hematopoietic complications. This case expands the clinical spectrum of biclonal gammopathy and underscores the value of comprehensive pathological evaluation for accurate diagnosis and tailored management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.